You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 4, April 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Double-Blind Study of Doxycycline in Acne Vulgaris

Gerd Plewig, MD; John W. Petrozzi, MD; Ulrich Berendes, MD

Arch Dermatol. 1970;101(4):435-438.


Abstract

To evaluate the effectiveness of doxycycline (Vibramycin) in acne vulgaris, 62 patients with predominantly inflammatory acne were treated in a double-blind crossover study. The drug was given orally, 100 mg/day, as a single dose every morning for four weeks. No concomitant internal or external therapy was permitted. Noninflamed open and closed comedones were not affected by active or placebo treatment. A good or excellent response in the reduction of inflammatory lesions was obtained in 21 (33%) of the subjects receiving doxycycline, compared to 14 (22%) while receiving placebo. Statistically, the improvement produced by doxycycline was significant, while there was no significant improvement from the placebo.



Author Affiliations

Philadelphia

From the Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia.


Footnotes

Accepted for publication Oct 20, 1969.

Reprint requests to the Department of Dermatology, Hospital of the University of Pennsylvania, Duhring Laboratories Building, 3600 Spruce St, Philadelphia 19104 (Dr. Plewig).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

What Proportion of Dermatological Patients Receive Evidence-Based Treatment?
Abeni et al.
Arch Dermatol 2001;137:771-776.
ABSTRACT | FULL TEXT  

Doxycycline Revisited
Joshi and Miller
Arch Intern Med 1997;157:1421-1428.
ABSTRACT  

Inhibition of a Model of In Vitro Granuloma Formation by Tetracyclines and Ciprofloxacin: Involvement of Protein Kinase C
Webster et al.
Arch Dermatol 1994;130:748-752.
ABSTRACT  

Topical v Systemic Agent Treatment for Papulopustular Acne: A Cost-effectiveness Analysis
Stern et al.
Arch Dermatol 1984;120:1571-1578.
ABSTRACT  

Zinc Sulfate in Acne Vulgaris
Weimar et al.
Arch Dermatol 1978;114:1776-1778.
ABSTRACT  

Effects of Oral Zinc and Vitamin A in Acne
Michaelsson et al.
Arch Dermatol 1977;113:31-36.
ABSTRACT  

Systemic Antibiotics for Treatment of Acne Vulgaris: Efficacy and Safety
Arch Dermatol 1975;111:1630-1636.
ABSTRACT  

Ecological Effects of Oral Antibiotics on the Microflora of Human Skin
Marples and Kligman
Arch Dermatol 1971;103:148-153.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.